PLA2G4C Antikörper (Internal Region)
-
- Target Alle PLA2G4C Antikörper anzeigen
- PLA2G4C (Phospholipase A2, Group IVC (Cytosolic, Calcium-Independent) (PLA2G4C))
-
Bindungsspezifität
- Internal Region
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PLA2G4C Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- PLA2G4C
- Sequenz
- NTEVIREYIF DQLR
- Spezifität
- This antibody is expected to recognize all reported isoforms (NP_003697.2, NP_001152794.1, NP_001152795.1).
- Kreuzreaktivität
- Human
- Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Güteklasse
- Verified
- Isotyp
- IgG
- Top Product
- Discover our top product PLA2G4C Primärantikörper
-
anti-Phospholipase A2, Group IVC (Cytosolic, Calcium-Independent) (PLA2G4C) (AA 1-189) antibody
PLA2G4C Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Phospholipase A2, Group IVC (Cytosolic, Calcium-Independent) (PLA2G4C) antibodyPLA2G4C Reaktivität: Human IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Phospholipase A2, Group IVC (Cytosolic, Calcium-Independent) (PLA2G4C) (Internal Region) antibodyPLA2G4C Reaktivität: Human WB, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Phospholipase A2, Group IVC (Cytosolic, Calcium-Independent) (PLA2G4C) (AA 1-541) antibodyPLA2G4C Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Phospholipase A2, Group IVC (Cytosolic, Calcium-Independent) (PLA2G4C) (AA 1-189) antibodyPLA2G4C Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Phospholipase A2, Group IVC (Cytosolic, Calcium-Independent) (PLA2G4C) (AA 301-350) antibodyPLA2G4C Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Western Blot: Approx 65 kDa band observed in Human Brain (Hippocampus), Liver, Pancreas, and Spleen lysates (calculated MW of 62.5 kDa according to NP_001152794.1). Recommended concentration: 0.03-0.1 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:128000.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
- Target
- PLA2G4C (Phospholipase A2, Group IVC (Cytosolic, Calcium-Independent) (PLA2G4C))
- Andere Bezeichnung
- PLA2G4C (PLA2G4C Produkte)
- Synonyme
- CPLA2-gamma antikoerper, phospholipase A2 group IVC antikoerper, PLA2G4C antikoerper
- Hintergrund
- PLA2G4C, phospholipase A2, group IVC (cytosolic, calcium-independent), CPLA2-gamma, DKFZp586C0423, FLJ42247, FLJ44164, cytosolic phospholipase A2 gamma, phospholipase A2, cytosolic, calcium-independent, gamma, phospholipase A2, group IVC
- Gen-ID
- 8605
- NCBI Accession
- NP_003697, NP_001152794, NP_001152795
- Pathways
- Inositol Metabolic Process, VEGF Signaling
-
